Big medtechs’ efficiency starts to recover from Covid

Big medtechs’ efficiency starts to recover from Covid

Source: 
EP Vantage
snippet: 

The sales a medtech company reaps per worker it employs is not the only measure of its efficiency, but it can be useful. It certainly highlights the tribulations of the sector through Covid, with 2021’s data indicating a major recovery in revenues and market cap among orthopaedics and cardiology companies.

It is still Intuitive Surgical that reigns supreme on this measure, however. At $490,000 in 2021 the robotic surgery leader’s sales per employee have ticked up from 2020 as lockdowns lifted and hospitals reopened for non-emergency procedures. This figure is still 4% lower than pre-pandemic 2019’s number, though, so the company has more ground yet to regain.